Wednesday, September 30, 2020

The Davis Companies Completes Fundraising for Fourth Fund

BOSTON--()--The Davis Companies announced today the closing of its latest value-add real estate fund, Davis Investment Ventures Fund IV, LP (DIV IV), with total equity commitments of US $777.5 million, significantly exceeding its original fundraising target of $650 million.  Commitments were made by a diverse group of limited partners, including public pension plans, insurance companies, endowments, foundations, family offices and high net worth investors. Park Madison Partners acted as the exclusive institutional Placement Agent on behalf of DIV IV.

We are extremely grateful for the strong support that we have received from our limited partners, including both long-standing and new investors,” said Jonathan Davis, Davis Companies Founder and CEO. “We plan to continue to bring to bear our core strengths in deploying Fund IV’s capital — our fully integrated operating platform focused on identifying and realizing on hidden value and market inefficiencies across economic cycles, our proven ability to capitalize on distress in downturns and our focus on markets where demand is driven by knowledge, innovation and positive demographic trends — to identify attractive investment opportunities for our investors.”

Quentin Reynolds, Davis Companies CIO, added, “We will be patient in deploying capital but are ready to invest as we identify compelling opportunities. Within our target markets, we remain hyper-focused on investments in life science, industrial, self-storage and multifamily properties. We also see opportunities to take advantage of distress, primarily through debt investments, where we have a long and successful track record.”

To date, the Fund has made seven investments, with equity commitments totaling approximately $165 million. The portfolio currently consists of a 17.8-acre last mile distribution development in Everett, MA, apartment development sites in two of Boston’s rapidly emerging neighborhoods, a self-storage development in Manhattan’s Chelsea neighborhood, a multifamily development in the Lake Norman neighborhood of Charlotte, NC and a student housing development in Athens, GA, home to the University of Georgia.  The Fund has also invested in a portfolio of 10 high-quality, well-protected mezzanine loans and several discounted CMBS positions.

About The Davis Companies

The Davis Companies is a 44-year-old, fully-integrated real estate investment, development and management firm based in Boston, MA. Since inception, the firm has invested across five market cycles, developed more than 8.5 million square feet, and owned more than 23 million square feet, representing more than $7.2 billion of transactions. The Davis Companies’ 10-person senior management team averages over 28 years of experience. The firm has a cross-disciplined team of 112 professionals with deep synergies to maximize performance and value. For more information, visit


Bloomscape Raises $15M in Series B Funding After Major Year of Growth

DETROIT--()--Bloomscape, the modern online garden center delivering the largest variety of quality houseplants directly from the greenhouse, today announced $15 million in new financing led by General Catalyst, bringing its total fundraising to $24 million. Joel Cutler, co-founder and Managing Director of General Catalyst and Bob Mylod, Managing Partner at Annox Capital Management will join Bloomscape’s Board of Directors. Bob Mylod, Jeff Boyd (Home Depot Board of Directors and formerly Chairman of Booking Holdings) and John Replogle (formerly CEO of Seventh Generation and Burt's Bees) are also contributing to the round with participation from existing investors including Revolution Ventures and Ludlow Ventures.

In addition to funding, Bloomscape is announcing the acquisition of Vera, the plant care app, which will provide customers access to plant care tips and content, troubleshooting, watering reminders and more. The app, Vera by Bloomscape, is yet another initiative toward Bloomscape’s mission to arm plant parents with ongoing plant care support, resources and tools to ensure plant parents have what they need to succeed.

Bloomscape will use the investment to:

  • Continue to grow premium plant care offerings - This includes the newly acquired Vera by Bloomscape app and extending its line of care products.

  • Grow the team - Bloomscape is focused on investing in employees and hiring a robust customer experience team, the “Grow-How™ Team,” to continue the company’s mission in supporting new plant parents in the plant care process through continued education and tools.

  • Build a world-class distribution model - Team is refining regional fulfillment strategy with the goal of installing localized centers and systems that shorten transit times leading to faster shipping.

  • Expand product offerings - With the success of the Edible Garden beta (which sold out in less than a week), Bloomscape is officially launching its Edible Garden Shop, including a small tomato, lavender, sweet pepper, hot pepper, kale mix, mint and chamomile plants as well as the aromatic, savory and spicy collections. Bloomscape is also announcing the company’s expansion into the outdoor plant category next year, as the team continues to pioneer the online garden space.

“We’re proud of the rapid growth our business has seen since launch, but this is just the beginning. With this new round of fundraising and the acquisition of the Vera app, we’re ready to take our product offering to the next level with new plants, tools and educational information to ensure our customers have everything they need to be successful plant parents, all in one place,” said Justin Mast, founder and CEO, Bloomscape. “Our business model is uniquely positioned for success in a time where ecommerce is key in consumer purchasing, and with our team’s historic knowledge of plant care and horticulture supply chain as well as distribution, we’re thrilled to be using our new funds to grow and continue in our mission to be the leading modern garden center for a new generation of plant lovers.”

Since its Series A round last year, the company has seen 4X growth and has more than doubled its team.

"You'd be hard pressed to find a team that understands a consumer vertical better than Bloomscape does with home gardening," said Joel Cutler, co-founder and managing director, General Catalyst. "The team has found not just excellence in the complicated logistics of cultivating and shipping live plants nationwide, but also a strong resonance with today's consumer who's looking to green up their living spaces."

About Bloomscape

Bloomscape is the modern garden center delivering the largest variety of quality houseplants directly from the greenhouse to peoples’ homes. Founded by a family of horticulturists dating back five generations, Bloomscape brings the greenhouse online for the first time with patented shipping technology making it the only service delivering plants of all sizes across the U.S. Located in Detroit, Michigan, Bloomscape’s mission is to strengthen people’s relationship with plants by delivering healthy, ready-to-go, potted plants and providing ongoing tips and advice needed to help them thrive. For more information, visit


HOMER, a BEGiN Brand, Raises $50 Million From LEGO Ventures, Sesame Workshop and Gymboree Play & Music

NEW YORK--()--BEGiN, the company behind the proven early learning program HOMER, announced today the close of a $50 million Series C funding round. Investors include LEGO Ventures, Sesame Workshop, the principal investor in Gymboree Play & Music, 3One4 Capital, Trustbridge Partners and Interlock Partners. Liquidity Capital also contributed an additional $25 million in trajectory-based funding for growth. The company will use the funding to 1) launch the industry’s first comprehensive early learning program across digital, physical, and in-person experiences 2) co-develop curriculum alongside trusted partners such as Sesame Workshop and 3) launch globally through distribution partners such as Gymboree Play & Music.

“HOMER is partnering with the largest, most recognized brands in international children’s education, entertainment, and technology to reimagine the early learning journey starting with parents and children at home.” said Neal Shenoy, CEO and co-founder of BEGiN, the parent company of HOMER.

“HOMER’s vision and approach to playful learning fosters curiosity and collaboration in children that aligns closely with LEGO Ventures’ investment ethos supporting founders and companies in bringing the LEGO idea of learning-through-play to life. We look forward to working with Neal and the excellent team he has built, and supporting HOMER as they grow and scale their purposeful play offerings across hands-on, in-person and digital experiences,” said Jamie Beaumont, Managing Partner, LEGO Ventures.

Evolving HOMER

HOMER has focused its efforts to date on reading, the first learning milestone for children. HOMER Reading and HOMER Stories comprise the #1 reading program in Apple’s App Store for children 5 and below, having earned numerous industry awards including Children’s App of the Year, Parent’s Choice, Teacher’s Choice, and Academics Choice. The success of HOMER has been its ability to deliver industry leading engagement to children alongside its proven ability to increase early reading scores by up to 74% in just 15 minutes of use a day. Since inception, HOMER has delivered more than four billion minutes of instruction across hundreds of thousands of subscribers.

With school closures as the new normal, HOMER has seen a 280% increase in annual subscriptions, 230% increase in website subscriptions, and children accessing 30% more lessons than this time last year. This comes on 80%+ year-over-year growth since launch.

Next week, HOMER will launch the industry’s first fully comprehensive early learning program, offering an expanded curriculum across reading, math, creativity, socio-emotional learning (SEL) and critical thinking skills delivered across digital, physical, and in-person learning experiences. HOMER’s program is based on The HOMER Method, a proprietary, expert-designed and research-based framework designed to give children the best start to their learning journey.

“With its focus on research and kid-centric design, and expansion to embrace the whole child curriculum, HOMER’s approach reflects the mission of Sesame Workshop to help kids grow smarter, strong and kinder,” said Steve Youngwood, President of Media and Education, and Chief Operating Officer of Sesame Workshop. “We’re excited to support HOMER’s growth and to look for further ways to partner with them to give young children the best possible start at a critical time of their learning and development.”

“Most digital curricula today is designed to be one-size-fits-all and focuses only on traditional academic skills. HOMER’s comprehensive program focuses on the whole child, teaching the essential school and life skills, and makes it easy for families to focus on what matters most in the early years.” said Stephanie Dua, co-founder and president of BEGiN.

Reshaping the board and executive team for growth

BEGiN is also adding several new members to its Board of Directors, headed by new Executive Chairman Siddharth Mathur, former Chief Strategy and Development Officer for Mattel and President of Babytree. Sid will bring his deep experience in leading two of the largest kids and parenting businesses globally to drive partnerships, strategic investment, and distribution for BEGiN.

“I’m humbled to join and lead the BEGiN Board of Directors as we bring together the experience and expertise of our incredible team and activate our strategic partnerships with some of the most respected brands and experts in children’s Education, Entertainment and Play. We strive to become the essential resource for families and parents to help their young kids develop critical foundational skills to help them succeed in school and life.” said Sid Mathur, Executive Chairman of BEGiN.

Steve Youngwood, President of Media & Education and Chief Operating Officer of Sesame Workshop, Jyoti Parikh, Head of Brand, Insights & Communication at LEGO Education, Xinkai Chen, Group Senior Vice President of Gymboree Global Education Group, and Michael Cohn, Partner at GSV will also join the Board of Directors.


BEGiN is the award-winning educational technology company that creates learning products that are as effective as they are engaging— cultivating critical skills and bringing high quality educational content to kids everywhere.

HOMER is the essential early learning program for kids 2-8. HOMER gives kids the best start to their learning journey by building confidence and developing skills that prepare them for school and life. The HOMER Method— our proprietary learning framework— delivers academic skills such as literacy and math, in addition to personal skills like problem solving and social emotional awareness, through content that is personalized to their interest, age, and learning level, during the critical time in early childhood development when kids’ brains are most hungry to learn.

To learn more visit,


Controlant Raises $15M in Series B Funding to Digitally Transform the Global Supply Chain

REYKJAVIK, Iceland and SAN FRANCISCO, Sept. 30, 2020 /PRNewswire/ -- Controlant, an emerging leader in digital supply chain visibility solutions, today announced that it has secured $15 million in Series B funding to drive market expansion of its real-time Cold Chain as a Service® Digital Visibility Platform, which brings unprecedented visibility, efficiency, and responsiveness to global temperature-controlled supply chains.

The oversubscribed round was led by current shareholders and local institutional investors. Also participating were existing and incoming private investors and family offices. Arion Bank Corporate Finance managed the placement. The financing brings Controlant's total funding to $50 million.

Controlant will utilize the capital to power the rapid expansion of its addressable markets, geographic footprint, and expanding customer base. The company is currently supporting the distribution of COVID-19 test kits and has partnered with global pharmaceutical manufacturers to monitor the distribution of COVID-19 vaccines, which, pending regulatory approval, are expected to begin shipping later this year.

"Our mission is to help companies ensure product integrity while increasing supply chain efficiency and serving their customers better. Our solution looks beyond traditional monitoring technologies and is automating product and information flows through actionable data, transforming supply chains from cost centers into strategic revenue generators," said Gisli Herjolfsson, Controlant co-founder and CEO. "Using our integrated platform technology and services, Fortune 500s and large enterprises gain a single source of truth across their end-to-end supply chains, while significantly reducing waste."  

Supply chain visibility for cold chain products is a growing need across global enterprises, specifically in areas such as:

  • Coordinating transport and cargo storage flow to ensure products reach key markets

  • Tracking product condition from manufacture through the last mile in a highly regulated industry

  • Managing supply chain data and processes across a complex, global network of stakeholders

  • Gaining a single source of supply chain truth by integrating multiple data streams

  • Proactively identifying and mitigating supply chain risk while reducing costs

Controlant's Cold Chain as a Service® solution is a powerful combination of IoT, advanced visibility and analytics through its cloud-enabled software platform, and cost-reducing operational services that increase workflow efficiency and responsiveness while supporting quality and compliance efforts.

Digitally connected cold chain monitoring and visibility technology has created enormous value for global enterprises, which are now looking for other areas that can automate, rendering data and process flows across the supply chain network as a tremendous opportunity. COVID-19 has exposed longstanding vulnerabilities and exacerbated the need for supply chains to remove silos and achieve greater agility and resilience.

The key benefits of Controlant are as follows:

  • Fast: Deployed quickly at scale, automates supply chain visibility data and processes across multiple stakeholders to increase efficiency.

  • Intelligent: Aggregates and harmonizes information streams, making it easier to identify risk areas and resolve them quickly.

  • Automated: Accelerates data collection and sharing between people and organizations, reducing friction and enabling them to collaborate more productively.

  • Empowering: Evolves the role of supply chain logistics from cost centers to strategic revenue generators through communication and data sharing.

  • Sustainable: Supports enterprise environmental goals to reduce global manufacturing and supply chain waste.

"Controlant is uniquely transforming the way global enterprises will collect, use, and share their supply chain data while optimizing their business operations," said Benedikt Gislason, CEO at Arion Bank. "The world's supply chains are undergoing a multi-trillion dollar shift to digital, and Controlant is in the vanguard as a leader in actionable visibility. We are pleased to support a leading Icelandic technology company as an investor and advisor as they lead the global market in the Cold Chain as a Service category."

To learn more about Controlant, visit and follow them @controlant and in/controlant.

About Controlant

Controlant's mission is to deliver value across the end-to-end supply chain by dramatically increasing the visibility of product flow and condition quality, while minimizing waste through a completely new category of automated Cold Chain as a Service® solutions. Using its IoT, cloud-enabled advanced analytics, API connectivity, and cost-reducing operational services, customers are achieving an annualized ROI and millions in savings, reducing material losses, and enhancing the reliability of their operations. Controlant is empowering Fortune 500s and world-leading enterprises in the pharmaceuticals & life sciences and food & beverage sectors and their supply chain stakeholders to achieve greater efficiency by automating their business processes and optimizing communication through technology.

Media Contact
Jessie VanderVeen, CMO
+354 690 5192
[email protected]

SOURCE Controlant

Related Links


Major Global Banks Invest $20 Million in BioCatch and Join American Express Ventures on New Client Innovation Board

NEW YORK & TEL AVIV, Israel--()--BioCatch, the global leader in behavioral biometrics, today announced that four major global banks – Barclays, Citi, HSBC and National Australia Bank (NAB) – have invested $20 million in the company, extending the company’s recent Series C fundraising round to a total of $168 million raised.

In conjunction with the funding, BioCatch has established the BioCatch Client Innovation Board. The invitation-only Innovation Board will be a collaborative forum where members will meet regularly to develop new, creative and cutting-edge ways to leverage and scale the unique attributes of behavior. The four investing banks and longtime BioCatch investor American Express Ventures will each be allocated two seats on the Client Innovation Board.

Innovation Board members will offer insights on the latest industry trends and ideas for new BioCatch offerings and technology. One of the board’s key focus areas will be on the development of advanced solutions that stay ahead of online fraud, which has proliferated since the advent of the coronavirus. BioCatch Client Innovation Board members will also work closely with each other and with the company to explore how collaboration and network effects can effectively combat online fraud and identity theft at an industrywide level.

Behavior provides powerful signals about whether online users are actually whom they purport to be, without revealing personally identifiable information. Flagging potential fraudsters before they can transfer funds from an account drives digital transformation and protects banks, their clients and their assets.

Innovation Board Members Comment:

The BioCatch Client Innovation Board is a novel, industry-led initiative focused on online behavior, which is a powerful method to protect banking customers and other internet users from online fraud,” said Dana Eli-Lorch, Managing Director at American Express Ventures. "Particularly as many businesses moved online with the emergence of the COVID-19 pandemic, preventing digital fraud has become more important than ever. We are very excited to join the effort and continue to support BioCatch both as an investor and Client Innovation Board member.”

Hilda Jenkins, Head of Customer for Digital Channels & Platforms across Mobile, Web & API at Barclays, said: “We are investing in BioCatch and joining the Innovation Board to build on our existing measures at Barclays that prevent fraud and scams. BioCatch is unique in focusing on behavior as a predictive tool to prevent online fraud and as a result can draw on a comprehensive data set to keep people safe. We’re looking forward to working with BioCatch and the innovation board members to further protect our customers and come up with innovative ways to stop fraud.”

"BioCatch is defining a novel category in digital engagements and has an impressive success record in the financial industry,” said Ornit Shinar, Head of Ventures Investments in Citi Israel. “We are excited to add BioCatch to the Citi Ventures portfolio."

"Behavioral biometric technology is a key strategic capability to protect our customers from the risk of fraud,” said Richard Harvey, Group Head of Retail Banking Products at HSBC. “BioCatch is a leader in this space and HSBC is looking forward to strengthening its partnership through this investment and through its role as part of the company’s newly formed Client Innovation Board.”

We invest heavily in the latest cyber security and fraud detection capabilities to protect our customers,” said Chris Sheehan, GM Group Investigations and Fraud, NAB. “In using device behavioral biometrics from BioCatch, we’re able to bolster our efforts to proactively detect fraud before the transfer of funds occurs, reducing the financial and emotional impact of scams for our customers.”

BioCatch CEO Comments:

We are extremely excited that five of the largest and most important global financial institutions are working with BioCatch to jointly address today’s most pressing problems in the areas of online fraud, account authentication and digital identity,” said Howard Edelstein, BioCatch Chairman & CEO. “We have already seen the power of collaboration in solving difficult problems in other areas of the financial services industry, such as clearing corps, transaction networks, post-trade processing, margin calculation and collateral management, when banks work together and share knowledge, workflow and data in the common interest.”

Background for Editors

BioCatch has used behavioral biometrics to root out online fraud since its founding in 2011 and the cache of behavioral data the company has accumulated over the decade since is unmatched. Through continuous authentication of online sessions, behavioral biometrics flags user digital behavior that presents potential risk, without collecting personally identifiable information (PII) that would compromise user privacy. As the company’s data set has grown to more than 150 million behavior profiles and tens of billions of transactions, products have expanded to include detecting stolen or synthetic identities being used at the onboarding stage, recognizing account takeovers and flagging increasingly sophisticated social engineering scams, among other industrywide security challenges.

About BioCatch

BioCatch pioneered behavioral biometrics, which analyzes an online user’s physical and cognitive digital behavior to protect users and their assets, all the while protecting user privacy. Today, customers around the globe leverage BioCatch’s unique insights to more effectively fight fraud, drive digital transformation and accelerate business growth. With nearly a decade of data, over 50 global patents and unparalleled experience analyzing online behavior, BioCatch is the leader in behavioral biometrics. For more information, please visit


Invetx Announces Completion of $25.5 Million Series A Financing and Key Appointments to Executive Team

BOSTON--()--Invetx, a pioneer in protein-based therapeutics for animal health, announced today that it has raised an additional $10.25 million in its Series A financing, bringing the total amount to $25.5 million. New investors include Casdin Capital and funds managed by Tekla Capital Management, LLC, joining existing lead investor Anterra Capital, as well as strategic investors AbCellera Biologics and WuXi Biologics. In addition, Invetx announced the appointments of Bill Brondyk, PhD, as chief scientific officer and Colin Giles, PhD, as chief development officer to its executive team.

“We are pleased to complete our $25.5 million Series A financing, welcoming blue-chip life science investors Casdin and funds managed by Tekla Capital Management, LLC to our investor syndicate. The company is now poised for rapid scaling of its novel platform and advancing its portfolio of innovative antibody therapeutics for veterinary use,” said Juergen Horn, PhD, chief executive officer, Invetx. “Additionally, we are thrilled to round out the Invetx management team with the additions of Dr. Brondyk and Dr. Giles. They bring a wealth of antibody and veterinary biologics development expertise to our company, as we look forward collectively to transforming the field of animal health.”

Dr. Brondyk was formerly senior vice president, platform discovery at Ohana Therapeutics, a reproductive health company, and head of U.S. biologics research at Sanofi, where he led the antibody discovery strategy. He received his PhD in oncology from the University of Wisconsin-Madison.

Dr. Giles was most recently senior vice president, clinical and regulatory affairs at Nexvet Biopharma, a leading veterinary biologics developer for companion animals acquired by Zoetis. He also served as vice president, veterinary medicine pharmaceutical R&D at Pfizer Animal Health. Dr. Giles received his veterinary degree and PhD in veterinary medicine from the Royal Veterinary College at the University of London.

The company also named scientific advisors Madhusudan Natarajan, PhD, head of rare diseases drug discovery at Takeda, and Rebecca Sendak, PhD, head of global large molecules research platform at Sanofi.

Invetx is developing a portfolio of novel products for chronic and serious conditions in pets with the goal to extend and improve their quality of life. The platform capabilities extend across a wide range of indications and targets, including challenging targets for drug discovery such as G-protein-coupled receptors (GPCRs), which account for a significant number of approved drugs in humans and which are also relevant in veterinary medicine. Invetx is initially focused on diseases in dogs and cats but is planning to apply its platform to indications in other major veterinary species. The company expects to begin pilot studies of its first development candidate in 2020.

Solebury Capital served as financial advisor to Invetx.

About Invetx

Invetx is building the world’s premier biotechnology platform for protein-based therapeutics in animal health to transform standards of care in veterinary medicine. The company completed a $25.5 million Series A financing in 2020 with investors Anterra Capital, Casdin Capital, funds managed by Tekla Capital Management, LLC and strategic investment partners AbCellera Biologics, a biotech company specializing in antibody discovery located in Vancouver, BC and WuXi Biologics, a global company with leading biologics technology platforms. Invetx is a private company headquartered in Boston, Massachusetts. For more information, see


Strigo Secures $8 Million Series A for its Customer Training Cloud After Tripling Customer Base During COVID-19

TEL AVIV, Israel, Sept. 30, 2020 /PRNewswire/ -- Strigo today announced that it has tripled its customer base since the outbreak of the COVID-19 virus and closed an $8 million Series A financing round. The new investment was led by Velvet Sea Ventures and existing investor Greycroft with participation from Hanaco, the company's lead seed investor.

Companies including Elastic, Mirantis, NCR, VMWare, Sage, and Zenika have adopted Strigo's unified platform to deliver remote instructor-led, on-demand and third-party training.

Strigo's Customer Training Cloud drives growth and retention by empowering customers throughout their relationship with the product knowledge and skills they need to maximize customer success. Customer training has become a critical business driver and software companies are making significant investments to scale and improve the quality of their training. With many software companies working remotely for the foreseeable future, Strigo has become an essential tool to drive customer success.

Strigo's clients are using the Customer Training Cloud to continually empower their customers by creating an ecosystem of hands-on training experiences that can be delivered in any format and at any time to best fit the needs of each customer. The platform centers around the product and eliminates the hassle of juggling various online applications by merging communication, content sharing, collaboration tools and product environments into a seamless experience.

"We are excited to lead the software industry toward our vision around the Strigo Customer Training Cloud. Our platform enables companies to deliver and scale impactful customer training to thousands of customers each month. We are especially proud of our ability to help companies quickly pivot to remote training since the outbreak of COVID-19," said Nevo Peretz, CEO of Strigo.

Today, efforts to effectively train customers often fall short as companies must patch together a number of tools that are not intended for customer training in order to deliver instruction. This results in poor training experiences and limits the ability to reach more customers. In addition, they lack data and insights to measure the effectiveness of their programs. These challenges have become more acute since the outbreak of the COVID-19 virus which has eliminated the opportunity for in-person training.

In addition to achieving high growth, Strigo is attracting top talent at every level of the organization. The company has hired Michael Jaindl as Chief Customer Officer to build out its customer success team globally. Prior to joining Strigo, Michael was VP Customer Success at Salesforce, which he joined after serving as Buddy Media's chief client officer before its sale to Salesforce for $800 million in 2012.

"Strigo is building a new category in the software industry with its Customer Training Cloud," said Michael Lazerow, partner and co-founder of Velvet Sea Ventures. "There is nothing more important for software companies than turning customers into power customers and Strigo is the first platform I have seen to do just that at scale. The market has already begun to embrace its vision for using a unified training platform that delivers the best training experience available and gives companies the flexibility and agility to provide a broad range of offerings in every format to empower their customers."

The company will use this round to scale up product development and its go-to-market strategy to meet rapidly increasing demand and to accelerate customer growth.

"As Strigo has further expanded into the market, there is a recognition that the company's innovative approach is helping software firms transform their customer training into a growth driver," said Will Szczerbiak, partner at Greycroft.

"We saw Strigo's great potential during the seed round, and Nevo and the rest of leadership has succeeded in making their vision into a reality," said Pasha Romanovski, co-founding partner at Hanaco and existing board member.

Read Strigo's latest blog: Customer Empowerment in the Age of SaaS.

About Strigo
Strigo transforms customer training for software companies, offering a new way to empower customers and drive growth and retention. Strigo's Customer Training Cloud enables companies to enhance their customers' product knowledge with hands-on training experiences that can be delivered in any format at any time to best fit the needs of each customer.

Leading venture capital firms, including Greycroft, Velvet Sea Ventures and Hanaco Ventures and back Strigo. Visit

About Velvet Sea Ventures
Velvet Sea Ventures is a multi-stage venture capital firm that helps entrepreneurs turn their visions into reality. With more than 80 years of combined experience as founders and venture investors and more than $2.2 billion invested, the firm provides seed-to-growth stage capital investments coupled with strategic support across all sectors. Velvet Seas partners' past investments include such notable companies as Twitter (TWTR), Square (SQ), SpaceX, Snap Inc. (SNAP), Facebook (FB), Pinterest (PINS), Domo (DOMO), Scopely, Buzzfeed, Namely, Eaze, Braze and Map Anything (CRM).

About Greycroft
Greycroft is a seed-to-growth venture capital firm that partners with exceptional entrepreneurs to build transformative companies. The firm has deep experience in both consumer and enterprise technology, with a portfolio that spans the globe. Greycroft values building enduring relationships with founders and understands that they want more from investors than just capital. Greycroft manages more than $1.5 billion in capital with over 200 investments, including Acorns, App Annie, Axios, Bird, Braintree, BetterCloud, Bright Health, Buddy Media, Huffington Post, Icertis, Lightricks, Openpath, Plated, Scopely, Shipt, TheRealReal, Thrive Market, Trunk Club, and Venmo.

About Hanaco Ventures
Hanaco Ventures backs early-stage technology companies with bold, visionary and passionate Israeli entrepreneurs, wherever they are across the globe. Hanaco was founded by Alon Lifshitz, Lior Prosor and Pasha Romanovski in 2017. For more on Hanaco, visit


Related Links


ClickSWITCH and USAA Announce Strategic Investment

MINNEAPOLIS--()--ClickSWITCH, a digital financial account switching solution, announced its most recent round of Series B-1 funding in the amount of $2 million from a USAA subsidiary. This brings the company’s external funding total to more than $21 million.

“This new round of funding will enable us to build additional momentum around the ClickSWITCH solution and its features,” said Cale Johnston, Founder and CEO of ClickSWITCH. “The financial investment from USAA is encouraging during these uncertain economic times and we are excited to support USAA’s mission of supporting the U.S. military community.”

The Series B-1 funding will accelerate ClickSWITCH’s ability to further innovate, solidifying ClickSWITCH as the leader in the account switching space. ClickSWITCH has over 500 financial institution customers in the United States and Canada and plans to continue growth by expanding its product offerings and hiring an additional ten to twenty employees by the end of 2020.

For USAA, the investment adds to a growing portfolio of investments with financial and insurance technology startups that help continue its proud tradition of delivering innovative products and services for the U.S. military and their families.

“Our mission is finding and delivering the best value in financial services for our military members, so they can take care of what’s important in their personal lives,” said Nathan McKinley, head of Corporate Development at USAA. “We were impressed by ClickSWITCH’s commitment to solving a persistent consumer problem and we look forward to helping them grow.”

About USAA

Founded in 1922 by a group of military officers, USAA is among the leading providers of insurance, banking and investment and retirement solutions to nearly 13 million members of the U.S. military, veterans who have honorably served and their families. Headquartered in San Antonio, Tex., USAA has offices in seven U.S. cities and three overseas locations and employs more than 35,000 people worldwide. Each year, the company contributes to national and local nonprofits in support of military families and communities where employees live and work. For more information about USAA, follow us on Facebook or Twitter (@USAA), or visit

About ClickSWITCH

ClickSWITCH is a digital account switching solution for financial institutions and challenger banks that simplifies the process of bringing new account holders onboard by quickly, safely and efficiently switching direct deposits and automatic payments to new accounts. The company enables financial institutions to make switching easy, capture more deposits, rapidly and consistently gain PFI status, and increase profitability. For more information, visit


Carmot Therapeutics Expands Leadership Team and Closes $47 Million Series C Financing to Advance Novel Incretin Receptor Modulators Through Phase 2 Studies

BERKELEY, Calif.--()--Carmot Therapeutics, Inc. (Berkeley, CA), a biotechnology company focused on bringing transformative therapies to patients with metabolic diseases, announced today a $47 million series C financing. The funding will support initiation early in 2021 of a 26-week dose ranging phase 2 study for CT-868 and phase 1-2 studies for CT-388 and involve more than 300 patients. Both programs are dual modulators of the GLP- 1 and GIP incretin receptors and have the potential to be best in a new class of treatments for type 2 diabetes, obese and fatty liver disease patients.

“Leveraging our transformative drug discovery platform, Chemotype Evolution (CE), Carmot has developed deep expertise in therapeutics targeting the GLP-1 and GIP incretin receptors,” commented Stig K. Hansen, PhD, Carmot’s co-founder and Chief Executive Officer. “Based on CT-868’s unique pharmacology we have seen a potential best in class therapeutic window in phase 1 studies that could translate into unprecedented improvements in HbA1c and weight loss for diabetic patients. In addition, both CT-868 and CT-388 have shown pre-clinically to be powerful insulin sensitizers which could translate into profound clinical benefits for patient populations across metabolic diseases”.

Amgen joined existing investors, The Column Group and Horizons Ventures, and other institutional investors in the round. In conjunction with the financing, Peter Svennilson, founder and managing partner of The Column Group, joined Carmot’s Board of Directors. In addition, James Watson joined Carmot as Chief Business Officer and led the series C financing process. Previously he was CBO & President ICT at Sigilon Therapeutics where he led a $485m diabetes partnership with Lilly. Prior, Mr. Watson was CEO of a boutique, life science investment bank and held leadership roles with Alvine, Incyte and Eli Lilly.

On joining the Board, Peter Svennilson commented: “Carmot has already developed valuable clinical assets, an innovative pipeline and a proven drug discovery platform. In addition, the Carmot team has a track record of successful strategic partnerships including the discovery collaboration with Amgen that led to Amgen’s breakthrough new KRAS inhibitor AMG 510. The investors and leadership team look forward to important new clinical data and attractive opportunities for further strategic partnerships and financing, all in the next 18 months”.

About Carmot Therapeutics, Inc.

Carmot Therapeutics (“Carmot”) is focused on the discovery and development of transformative therapies for patients with metabolic disease. Carmot applies Chemotype Evolution (CE), a pioneering drug discovery technology, in combination with unique biological expertise to identify innovative and superior therapeutics. In metabolic disease, Carmot is combining CE with novel insights into incretin receptor signaling to develop a broad, valuable pipeline of peptide-based and small molecule therapeutics. Carmot’s lead program, a dual GLP-1/GIP receptor modulator, is entering phase 2 development and has the potential to be best in a new class of treatment for type 2 diabetes, obese and fatty liver disease patients. In addition, Carmot is internally, and with partners, using CE to identify novel covalent inhibitors and to develop new therapeutics targeting major oncogenic pathways. Carmot has successfully applied CE with strategic partners including the discovery collaboration with Amgen that led to AMG 510, the first KRAS inhibitor to enter the clinic.


Sonoma Biotherapeutics Expands Series A Financing to $70 Million and Appoints Key Executives to Advance Regulatory T-cell Therapies in Autoimmune and Degenerative Diseases

SOUTH SAN FRANCISCO, Calif. & SEATTLE--()--Sonoma Biotherapeutics, a privately held company developing regulatory T-cell (Treg) therapies for autoimmune and degenerative diseases, announced that it has raised an additional $30 million from investors in its Series A financing, bringing the total to $70 million. Investors participating in the round include Lyell Immunopharma, ARCH Venture Partners, 8VC, LifeForce Capital, Lilly Asia Ventures Biosciences, Octagon Capital, Alexandria Venture Investments, the JDRF T1D Fund and additional undisclosed investors.

Sonoma also announced three new appointments to the senior management team: Leonard Dragone, M.D., Ph.D., joins as chief medical officer; Sejal Hall, Ph.D., joins as vice president of portfolio, program and alliance management; and Susan Lacy, Ph.D., joins as vice president of discovery. They join an experienced team steeped in next-generation research, development and manufacturing capabilities in immunology, cell therapy and genetic engineering.

“We have made significant progress in a short amount of time in our mission to move adoptive cell therapy beyond cancer and into other disease areas, including autoimmunity and neuroinflammation,” said Co-Founder and CEO Jeffrey Bluestone, Ph.D. “Our progress in applying cell therapy to reprogram the immune system to alter the course of disease has attracted the attention and the vision of talented scientists and drug developers, as well as proven investors.”

  • Leonard (Lenny) Dragone, M.D., Ph.D., has joined Sonoma as chief medical officer. Lenny joins from Janssen Biopharma, where he served as vice president for early clinical development in infectious diseases. Lenny has extensive leadership experience across multiple cross-functional project teams, driving development in a wide range of disease indications. Prior to Janssen, he served as Merck’s therapeutic area lead for autoimmunity, inflammation and ophthalmology, and prior to that worked in multiple autoimmune indications at Genentech.

  • Sejal Hall, Ph.D., has joined Sonoma as vice president, program, portfolio and alliance management. Sejal joins Sonoma from Audentes Therapeutics, where she was executive director, research operations and program management. Prior to that, she held roles in program management, alliance management and business development at Denali Therapeutics, iPierian and Novartis. Sejal has extensive experience in managing global cross-functional project teams and partnerships, from research through early clinical development across a range of modalities and disease indications in neuroscience, immunology, hematology and rare disease.

  • Susan Lacy, Ph.D., has joined Sonoma as vice president of discovery. Susan joins from AbbVie (and previously Abbott), where during her 20-year tenure she held positions including director, immuno-oncology discovery and project director, immunology drug discovery. Susan generated and delivered numerous innovative drug candidates with complete preclinical data and Investigational New Drug (IND) submission packages to clinical development through her leadership within highly matrixed, multi-disciplinary teams. She established and led several teams in immunology and oncology focused on technology, pathway biology and target identification.

“This expansion of the Sonoma team and the Series A financing will enable Jeff and the rest of the organization to continue their great progress,” said Dr. Rick Klausner, executive chairman of Lyell Immunopharma and chair of the Sonoma Biotherapeutics board of directors. “They are well poised to drive the next generation of cell therapy forward to advance treatments and potentially cures for patients with significant unmet medical need.”

About Treg Cell Therapy

The goal of Treg therapy is to restore a state of self-tolerance by halting harmful inflammatory responses in autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, along with degenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s. Over 50 million Americans currently live with an autoimmune disease, and millions more with some form of degenerative disease. For many, existing therapies are ineffective at controlling their disease.

Treg cells have a clear role in many of these conditions. These cells’ natural ability to migrate to inflamed tissues and control harmful immune responses makes them ideal for treating a range of conditions. In addition, the ability to engineer Treg cells to target specific disease-causing antigens reduces the potential for unwanted systemic effects. The role of Treg cells in tissue maintenance and repair offers the potential for effective, durable and restorative treatments.

About Sonoma Biotherapeutics

Sonoma Biotherapeutics is a South San Francisco and Seattle-based company leading the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies. More information at


Enhanced Healthcare Partners Announces Investment in NeuroPsychiatric Hospitals

NEW YORK--()--Enhanced Healthcare Partners (“EHP”), a leading healthcare-focused private equity firm specializing in middle-market healthcare services businesses, is pleased to announce its investment in NeuroPsychiatric Hospitals (“NPH”), a leading provider of integrated healthcare for patients with acute psychiatric disorders and complex medical and neurological disorders.

Founded in 2006, NPH utilizes an integrated model of care supported by an interdisciplinary team of healthcare practitioners to ensure the diverse needs of each of their patients are addressed. Unlike the traditional hospital emergency room or a psychiatric care facility where the clinical staff is not equipped to care for patients with both psychiatric and medical issues, NPH’s clinical staff have expertise across multiple disciplines including psychiatric, behavioral, neurological, and medical disorders.

The funding from EHP will be used to advance NPH’s expansion efforts and strategic objectives. NPH currently has four locations in Indiana and plans to open additional hospitals in Arizona and Texas during the second half of 2020. EHP will partner with NPH Founder and CEO Cameron Gilbert, PhD, at this inflection point, and together they will continue to build upon NPH’s platform designed to meet the needs of this significantly underserved psychiatric and medical patient population. EHP and NPH have plans for further expansion nationwide.

We are excited to partner with EHP as we accelerate our growth and expansion efforts. EHP has deep experience scaling healthcare organizations that have demonstrated the ability to care for highly acute patient populations, which aligns with our core mission,” said NPH Founder and CEO Cameron Gilbert, PhD. “We see the ability to continue to improve patient care and reduce hospital readmissions, while geographically expanding our company’s reach.”

NPH’s ability to comprehensively address the needs of patients with complex behavioral and medical needs is compelling, especially since these patients often do not have other options for care. By using a patient-centered model, the company delivers best-in-class outcomes for their patients, which aligns well with our experience and furthers our excitement about this partnership,” said EHP Principal Brandon Einstein, MD.

NPH was advised by Cantor Fitzgerald. Terms of the transaction were not disclosed.


Enhanced Healthcare Partners is a leading healthcare-focused private equity firm dedicated to making minority and majority investments in founder and entrepreneur-led lower middle-market companies. The EHP team has managed approximately $1 billion in equity capital and is comprised of professionals with deep healthcare, operations, consulting and investment management experience. The firm seeks to invest in companies between $50-$250 million in enterprise value, driving deep partnerships with management and founders to catalyze growth and build great organizations. For more information on EHP visit:


NeuroPsychiatric Hospitals specializes in providing care for patients with complex behavioral, neuropsychiatric, and medical needs. Founded in 2006 by Dr. Cameron Gilbert, NeuroPsychiatric Hospitals utilizes an integrated healthcare model at each of its hospitals. Interdisciplinary teams consisting of physicians, nurses and other healthcare professionals ensure that all patient conditions are addressed to “better heal the body and the mind.” NPH currently operates four facilities in the Midwest and has announced the opening of hospitals over the next few months in Arizona and Texas. For more information, visit


Tuesday, September 29, 2020

D.A. Davidson Secures Funding to Pave the Way for Aurora Developments Along High-Profile Airport Corridor

DENVER--()--D.A. Davidson & Co. has secured nearly $92 million of tax-exempt bonds to fund new development at the southeast corner of the high-profile intersection of Interstate 70 and E-470 and at the intersection of E-470 and 64th Avenue in Aurora. The financings, issued in two separate transactions secured by property under development by Westside Investment Partners, provide funding for the Aurora Crossroads and High Point developments.

These financings are the latest in a successful series of special district transactions in recent years that have raised $1.2 billion in capital to finance public infrastructure in and surrounding the airport growth corridor, which spans developments in Denver, Aurora and Commerce City. Projects in early stages of development have benefited from a low interest rate environment, with the Aurora Crossroads bonds being issued at 4.625 percent and 4.875 percent rates.

“The Davidson team was pleased to raise significant infrastructure dollars for the Aurora Crossroads and High Point developments, which will ensure the continued development of these high-profile locations in the City of Aurora and the greater airport growth corridor notwithstanding current uncertainties,” said Laci Knowles, senior vice president, Special District Group at D.A. Davidson. “Growth in our state pays its own way, and these early stage financings continue to pave the way for incredible new projects that will provide important services and a sense of community for city residents and airport visitors alike.”

Aurora Crossroads includes about 209 acres of land under development at the southeast intersection of I-70 and E-470. The portion of High Point securing this latest financing is approximately 272 acres along 64th Avenue north of Painted Prairie and intersected by E-470. Upon completion, the projects are planned to include:

  • A six-story regional hospital and medical offices adjacent to Aurora Crossroads.

  • The JP Morgan Chase bank data center, which opened early in 2020 at the Aurora Crossroads site.

  • A 125-room hotel and over 300,000 square feet of commercial development at Aurora Crossroads.

  • A 100-room hotel and 713 multifamily residences at High Point.

  • Mixed use development at High Point that will include 800,000 square feet of retail, 175,000 square feet of mixed use commercial and another 175,000 square feet of office space.

  • Another 152 acres planned for industrial development at High Point.

These early stage bond transactions were managed by the Special District Group at D.A. Davidson, comprised of 17 individuals exclusively dedicated to financing public infrastructure across the country. The group has extensive transaction experience, with over 100 transactions and over $2 billion of par amount issued in the past year.

D.A. Davidson & Co.’s Fixed Income Capital Markets group is a national leader in raising capital through fixed income banking, distribution and depository strategy. With 30 locations in 19 states, the group is consistently ranked among the top firms in the country. The fixed income team serves new issue clients in public finance and taxable debt issuance, and maintains a diverse sales and trading group interacting with taxable and tax-exempt investors including banks, credit unions, insurance companies, bond funds, money managers and trust companies.

About D.A. Davidson Companies

D.A. Davidson Companies is an employee-owned financial services firm offering a range of financial services and advice to individuals, corporations, institutions and municipalities nationwide. Founded in 1935 and headquartered in Montana, with corporate offices in Denver, Los Angeles, Portland and Seattle, the company has approximately 1,400 employees and offices in 26 states.

Subsidiaries include: D.A. Davidson & Co., the largest full-service investment firm headquartered in the Northwest, providing wealth management, investment banking, equity and fixed income capital markets services, and advice; Davidson Investment Advisors, a professional asset management firm; D.A. Davidson Trust Company, a trust and wealth management company; and Davidson Fixed Income Management, a registered investment adviser providing fixed income portfolio and advisory services.

For more information, visit



Vacmobile Corporation Selected as an ATDC Healthcare Tech Venture Showcase Company

ATLANTA, Sept. 29, 2020 /PRNewswire/ -- Vacmobile Corporation based in Alpharetta, GA, announced today that it is one of only 14 healthcare technology companies that were selected by the Advanced Technology Development Center (ATDC), the state of Georgia's globally recognized technology incubator, for its 2020 ATDC Venture Showcase Sept. 29-Oct. 1.

Jennifer Sparks, Vacmobile CEO said, "We are honored to have been chosen by the ATDC to share our healthcare SaaS mobile app and enterprise software solution. We are focused on providing digital access, storage and transmission of certified vaccination and pandemic health status records. The bottom line is that consumers' access to their own vaccination records is mission critical. People should be able to obtain, store and transmit their HIPAA compliant digital vaccination records and their health status records, including Covid-19 test records, directly from their smartphones."

Serena Sacks-Mandel, a Vacmobile Advisor, and Microsoft National Customer Success Leader, stated, "I am very excited by Vacmobile technology which not only will empower consumers with the knowledge they need to make sure they and their loved ones are up to date on their vaccinations, but also will streamline families' vaccination record keeping and help public and private enterprises maintain compliance and mitigate risk. Vacmobile offers the roadmap to reopen safely."

Currently, certified vaccination records required by law for school and college enrollment or needed to obtain or maintain employment are generated on paper and accessed predominantly in person. Vacmobile provides the consumer an easy way to obtain, store and transmit digital vaccination records and digital pandemic health status records easily from your smartphone. Conversely, Vacmobile provides enterprises a way to dramatically improve their compliance and access advanced analytics.

"These Showcases are designed and curated for investors to show Georgia's rich ecosystem with a portfolio of high-caliber healthcare technology companies," said ATDC Investor Relations Manager Brad Schweizer. "Venture capitalists can see firsthand the funding potential and outstanding tech talent in Georgia and at ATDC."

In each of the last three years, ATDC portfolio companies have raised more than $100 million and since launching the ATDC Venture Showcases in 2017, Georgia-based tech companies have raised more than $80 million from investors who attended these events.

About the Advanced Technology Development Center:
The Advanced Technology Development Center (ATDC), a program of the Georgia Institute of Technology, is the state of Georgia's technology startup incubator. Founded in 1980 by the Georgia General Assembly, which funds it each year, ATDC's mission is to work with entrepreneurs in Georgia to help them learn, launch, scale, and succeed in the creation of viable, disruptive technology companies. Since its founding, ATDC has grown to become one of the longest running and most successful university-affiliated incubators in the United States, with its graduate startup companies raising $3 billion in investment financing and generating more than $12 billion in revenue in the state of Georgia. To learn more, visit

About Vacmobile Corporation
Vacmobile offers integrated SaaS mobile, enterprise software, and advanced analytics solutions used to obtain, store and transmit certified digital vaccination records and pandemic health status records. Individuals use the app to manage their vaccination history and compliance. Large scale institutions will license the mobility and enterprise software solution to receive and share those certified digital records and test results as required by law. Pandemic analytics and mitigation solutions, including a companion app to read the "healthy QR codes" will allow organizations to safely resume face to face interactions.  To learn more about Vacmobile, visit

SOURCE Vacmobile Corporation; ATDC

Related Links


St. Cloud Capital Announces Growth Capital Investment In Morrow Sodali

LOS ANGELES, Sept. 29, 2020 /PRNewswire/ -- St. Cloud Capital is pleased to announce an investment in New York-based Morrow Sodali Global, LLC (the "Company").  It is an investment out of St. Cloud's third fund, which has committed capital of $250 million.

The Company is a leading provider of strategic advisory and shareholder services to corporate clients around the world.  Morrow Sodali provides corporate boards and executives with strategic advice and services relating to corporate governance, shareholder and bondholder communication and engagement, capital markets intelligence, proxy solicitation, shareholder activism and mergers and acquisitions.  From headquarters in New York, and offices and partners in major capital markets, Morrow Sodali serves more than 700 corporate clients in 40 countries, including many of the world's largest multinational corporations.  In addition to listed and private companies, its clients include mutual funds, ETFs, stock exchanges and membership associations.

Alvise Recchi, Chief Executive Officer of the Company is excited to partner with St. Cloud to continue the Company's growth. "St. Cloud's investment further strengthens our balance sheet and will provide the resources for strategic opportunities we are considering as part of our growth strategy."

St. Cloud Capital Managing Partner Robert Lautz commented, "We believe the Company's extensive breadth of service offerings has allowed it to outpace others.  We look forward to working with Alvise and the entire management team to continue expanding the business." 

For more information about Morrow Sodali, please visit

About St. Cloud Capital

St. Cloud Capital is a Los Angeles, CA-based private investment firm that provides growth capital to the lower middle market (companies with annual revenues generally between $10 million and $150 million) throughout the United States. St. Cloud typically invests $5 million$20 million in companies across a wide range of industries in every layer of the capital structure, including senior secured debt, subordinated debt, and preferred and common equity. St. Cloud's investment discipline includes non-control and control investments, and involves partnering with strong management teams or experienced industry entrepreneurs. For more information about St. Cloud Capital, please visit

Contact: Matt Smith, [email protected]

SOURCE St. Cloud Capital

Related Links


OmniView Sports Announces Raise of Seed Round to Accelerate to Market

"Sports fans around the country are missing the moments that matter most to them because of a fractured viewing experience," said Nikhil Patel, Chief Executive Officer of OmniView Sports. "Our latest seed financing round will help us accelerate to market to maximize these opportunities for change."

OmniView Sports created YourZone, an easy-to-use app that integrates fantasy leagues and sportsbooks to personalize how fans watch sports.

This app uses sports-play feeds, machine learning, and odds-pricing simulations in real-time to calculate Excitement Metrics based on a user's interests. 

Key features of YourZone powered by GameChangr include:

  • Seamlessly connects to cable, streaming services, and fantasy/sportsbooks. 

  • Choose your favorite sports, teams, and players and easily watch each of your selections by clicking the TV or stream button. 

  • Ability to see fantasy players score points in real-time rather than be alerted after. 

  • Find the best odds and place bets at your favorite sportsbook within the app.

  • Receive alerts when a big play is about to happen.

When talking about YourZone, M.L. Carr, former Boston Celtics player, Coach, and General Manager said it best, "It's like NFL RedZone on steroids!"

With an increase in cord-cutting and streaming options as well as sports broadcast viewing, the market is primed for innovation that creates a multi-dimensional viewing experience. Through this seed round, OmniView Sports is confident they'll deliver a product that wraps all of these key elements into a smart, personal sports hub. 

For more information about OmniView Sports, click here

About OmniView Sports' GameChangr

The GameChangr turns your smartphone into an all-sports universal remote and integrates all your fantasy leagues and sportsbooks in one easy-to-use app, YourZone. With YourZone app's predictive play notifications, the GameChangr gets you to any game before an epic play happens.

Media Contact: [email protected]

SOURCE OVS Technologies, Inc.


Buzzer Secures $4 Million Seed Funding Led by Lerer Hippeau and Sapphire Sport

NEW YORK, Sept. 29, 2020 /PRNewswire/ -- Buzzer, a mobile platform for live sports personalized for fans and authenticated through existing subscriptions or micropayments, today announced the close of a $4 million seed funding round. The funding was led by Lerer Hippeau, the most active early-stage venture capital fund in New York, and Sapphire Sport, a first-of-its-kind venture fund investing in the future of consumer experiences through personalization, connectivity and digital commerce. The Company also raised capital from investors, including R&R Venture Partners and Imagination Capital, as well as leaders across the sports, media and technology industries, such as Sofi CEO Anthony Noto, former Chairman and CEO of Time Warner and interim CEO of the LA Clippers Richard Parsons, and former Twitter Head of Design & Research Grace Kim.

Buzzer's mobile platform will provide a seamless user and viewing experience by aggregating sports rights and content and allowing its users to set up customized notifications. Fans have the option to either authenticate an existing subscription through Buzzer or instantaneously make a secure micropayment to buy only and exactly what they want to watch. Through this unique and innovative technology, Buzzer's technology identifies 'lightning in a bottle' moments in live sports so fans never again have to miss the sports moments that matter most to them as they're happening.

"Sports is the ultimate unifier – it brings together people from all backgrounds through moments of triumph and unforgettable experiences – that's why our foundation is built upon a true sense of community," said Bo Han, Founder and CEO of Buzzer. "Our mission is to provide all sports fans, from the casual observer to the avid season ticket holder, unmatched access to personalized live sports action anytime, anywhere. With this investment, we are well-positioned to introduce an innovative way for fans to engage with the teams and athletes they love, and to mindfully build a product that creates complementary value for the industry by establishing a third category of sports rights -- short-form live on mobile. The creation of this category, which sits in-between live long-form on TV and short-form near live clips on social and digital platforms, advances the existing ecosystem by creating awareness of these live games and enhances the value for existing media rightsholders."

Ken Lerer, Managing Partner at Lerer Hippeau, said, "Across leagues, over-the-top subscriptions and multichannel video programming distributors, we see more than a dozen different platforms for fans to stream sports and it's nearly impossible for a sports fan to keep track of when, where and how to watch. Today's consumers expect content to be immediately accessible, consumable, personalized for their interests, and tailored for their devices. Given consumers' demand and appetite for aggregated sports content, we couldn't be more excited about Buzzer and its position to be a go-to aggregated live sports streaming platform for fans everywhere."

"We are living in a world where the local, national and global media rights are still the norm, and in some cases are the only thing holding the global sport economic ecosystem together," said Michael Spirito, Managing Director at Sapphire Sport. "The sports industry – now more than ever before – is in need of unique technology solutions like Buzzer. Buzzer's platform creates strong partnerships with networks, leagues, teams and athletes alike in order to increase the overall value proposition for all stakeholders and make programs accessible to new consumers and demographics."

According to Anthony Noto, CEO of Sofi, previous COO of Twitter, and previous CFO of NFL, "The one constant in the world of media content and distribution is innovation. Buzzer is the tip of the spear on the next frontier of media innovation. Buzzer will uniquely capture the attention of Millennials and Gen Z that are not subscribed to pay-TV or can't access their subscription away from home. It will unlock a new form of innovation for rights owners as this is an entirely new type of window and content that will give birth to new creativity."

In addition to closing the gap between live sports and modern consumption habits, Buzzer also has a mission to build a community for the sports world – this starts with its own company. In alignment with its purpose-driven mission, Buzzer created and spearheads a mentorship program that pairs industry leaders across sports, technology, and media with student mentees from across Historically Black Colleges and Universities (HBCUs) to cultivate and invest in the next generation of industry leaders. In its inaugural year, the team paired over 1,000 mentors and mentees across the U.S. In addition to the mentorship program, Buzzer has committed to an initiative its calling 'Strive,' defined by a 1x1x1 model: 1% of company equity, 1% of net profits, and 1% of customer-elected transactions will be dedicated to investing in equitable outcomes for Black, Indigenous and People of Color.

About Buzzer
Buzzer is a notification-driven mobile platform for live sports personalized for fans and authenticated through existing subscriptions or micropayments. Founded in 2020 by Bo Han, former Head of Live Sports Rights Acquisition at Twitter, Buzzer is a mission-driven company that brings people together by making their favorite sports moments accessible.

Buzzer is headquartered in New York and has 16 employees across the U.S. To learn more, visit and follow @Buzzer on Twitter.

About Lerer Hippeau 
Lerer Hippeau is the most active early-stage venture capital fund in New York. The firm has more than 250 active portfolio companies with investments in leading consumer, media, and enterprise companies. Lerer Hippeau invests across all sectors, backing founders with product vision, customer insight, and a keen instinct for brand building. For more information please visit

About Sapphire Sport
Sapphire Sport is the first-of-its-kind venture fund dedicated to investing in early-stage companies at the intersection of technology, sport, media and entertainment. Launched in 2019, Sapphire Sport brings together investors from more than two dozen sport, media and entertainment organizations globally, including City Football Group, owners of English Premier League Manchester City; Anschutz Entertainment Group (AEG); the ownership of the Indiana Pacers; and WISE Ventures, an investment fund led by the Wilf family, real estate developers and professional sports team owners. For more information please visit


Related Links


Delaware Innovation Space Makes $265,000 in First Fund Investments

WILMINGTON, Del.--()--Delaware Innovation Space, a multi-dimensional, non-profit incubator and accelerator for science-based start-up companies, announced today that it has invested a total of $265,000 in three companies, including Gaskiya Diagnostics, Layer Metrics and Revolve Biotechnologies.

All three companies will join the Delaware Innovation Space as new resident companies in addition to receiving capital investments. Each company was selected from a pool of over 50 startups that had applied earlier this year for First Fund investments.

“The Delaware Innovation Space continues to intensify our support for early stage science entrepreneurs and the First Fund is that next step,” said Bill Provine, President and CEO of the Delaware Innovation Space. “Gaskiya Diagnostics, Layer Metrics and Revolve Biotechnologies are perfect adds to the portfolio of companies that call the Delaware Innovation Space home – scalable, high potential, impactful, and investable startups led by driven entrepreneurs moving science from the lab to the marketplace with speed and intensity.”

Gaskiya Diagnostics serves the $250 billion/year aquaculture industry by enabling farmers to quickly diagnose disease in their stock and take immediate action to mitigate its impact. No specialized training or equipment are needed to perform the tests, making them broadly accessible to farmers of all skill sets. Rapid diagnosis leads to faster treatment, fewer losses and more quality food to meet global demand.

“The Delaware Innovation Space offers precisely what Gaskiya needs at our current stage of accelerated product development, and we are thrilled to be a part of it,” said Mary Larkin, PhD, CEO with Gaskiya Diagnostics. “The access to shared equipment facilities, as well as generous lending of equipment to our lab, are helping us to quickly get up and running in our new space. The First Fund investment is meeting several critical needs for our company’s growth, including growing our team in order to expedite and expand our product development to best meet the needs of our customers.”

Layer Metrics Inc. is an optical monitoring company focused on quality control for 3D metal additive manufacturing (AM). AM printing is a volatile multi-faceted process that is difficult to control and prone to distortions. The Layer Metrics team has developed a new optical hardware sensor system to monitor and detect flaws during the manufacturing process. This enables the user to take corrective action while the part is being printed. The Layer Metric patent pending system captures an amalgam of real-time synchronized data to deliver confidence in build-integrity of 3D metal printed parts. This key enabling refinement of the AM process will fuel rapid growth as AM transitions from high-end, low-volume to mass manufacturing.

“Layer Metrics is excited and privileged to be among the first companies to receive an investment from the Delaware Innovation Space and its First Fund,” said Clare Murphy, CEO of Layer Metrics. “Additionally, access to this world-renowned, vibrant ecosystem connects us to new opportunities that are backed by a distinguished, broad-based and deeply experienced team. Supported by Delaware Innovation Space, Layer Metrics is accelerating its new monitoring technology to the marketplace.”

Revolve Biotechnologies serves the drug development industry by unlocking the full potential of protein engineering. The core technology, licensed from Johns Hopkins University, drives novel creation of optimized proteins for therapeutics, diagnostics and research tools. Revolve generates comprehensive DNA variant libraries four times faster and provides up to 1000x more coverage than competing technologies. Revolve currently sells to the biopharmaceutical industry as well as develops its own enzyme and antibody-based therapeutics.

“The Delaware Innovation Space is the perfect location for Revolve to provide services to our customers,” says Alex Meltzer, PhD, CEO of Revolve. “With a strong scientific community of other successful biotech companies, Revolve will be immersed in an ecosystem built to drive innovation. The First Fund investment, combined with the state-of-the-art facilities and equipment of the space, will allow Revolve to focus on growing revenue with the confidence that it can meet customer demand.”

Science and technology-focused entrepreneurs who would like to apply for funding from the First Fund at the Delaware Innovation Space can apply via our application website. More details on the program can be found here.

About Delaware Innovation Space:

Delaware Innovation Space is a multi-dimensional, non-profit incubator & accelerator for start-ups that leverages the expertise, resources, and infrastructure of the world renown Experimental Station campus in Wilmington, Delaware. It is the result of a public-private partnership between the State of Delaware, DuPont and the University of Delaware. Delaware Innovation Space is an ecosystem where scientists, business leaders, community members, investors, and service providers in the industrial biotech, advanced materials, chemical ingredients, renewable energy, nutrition and healthcare fields can build business concepts together and accelerate the path to commercialization. Learn more:


Echo Health Ventures Introduces New Innovation Alliance Bringing Together Three National Health Care Leaders to Collectively Invest in Transforming Health Care

The EIA further validates Echo's unique model and will accelerate our work with leading entrepreneurs -Rob Coppedge, CEO Tweet this The ...